INMB

INmune Bio, Inc.NASDAQHealthcare

$1.21+1.65%ClosedMarket Cap: $32.2M

As of 2026-04-06

Analyst Consensus

Consensus

Buy

Target (Consensus)

$22.00

Target (Median)

$22.00

Target Range

$22.00 - $22.00

Upside from current price: 1718.2%

Rating Distribution

1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-11	LUCID CAPITAL MARKETS	upgrade	Buy	Neutral
2025-07-02	Maxim Group	maintain	Buy	Buy
2025-07-01	Scotiabank	downgrade	Sector Underperform	Sector Outperform
2025-07-01	BTIG	downgrade	Neutral	Buy

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-0.94	$133.3K	2
Fri Dec 31	$-0.97	$6.7M	2
Sun Dec 31	$-0.31	$31.9M	2
Mon Dec 31	$1.01	$96.6M	1